HK Stock MarketDetailed Quotes

02373 BEAUTYFARM MED

Watchlist
  • 15.140
  • -0.120-0.79%
Not Open May 20 16:08 CST
3.57BMarket Cap15.00P/E (TTM)

BEAUTYFARM MED Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Turnover
31.16%2.15B
41.20%1.04B
-8.16%1.64B
-12.25%734.32M
18.46%1.78B
--836.83M
7.02%1.5B
--1.4B
Operating income
31.16%2.15B
41.20%1.04B
-8.16%1.64B
-12.25%734.32M
18.46%1.78B
836.83M
7.02%1.5B
1.4B
Cost of sales
-27.29%-1.17B
-32.95%-558.76M
3.10%-917.57M
6.16%-420.29M
-17.89%-946.95M
---447.88M
-15.34%-803.27M
---696.41M
Operating expenses
-27.29%-1.17B
-32.95%-558.76M
3.10%-917.57M
6.16%-420.29M
-17.89%-946.95M
-447.88M
-15.34%-803.27M
-696.41M
Gross profit
36.12%977.1M
52.25%478.11M
-13.91%717.84M
-19.26%314.03M
19.11%833.79M
388.95M
-1.17%700.02M
708.34M
Selling expenses
-31.66%-378.17M
-38.82%-166.92M
4.09%-287.23M
7.75%-120.24M
-10.70%-299.46M
---130.34M
2.68%-270.52M
---277.97M
Administrative expenses
-7.76%-318.35M
0.85%-165.84M
-8.44%-295.43M
-26.87%-167.26M
-21.60%-272.45M
---131.84M
5.61%-224.06M
---237.38M
Research and development expenses
-9.25%-34.07M
-14.62%-17.18M
-72.98%-31.19M
-93.42%-14.99M
-42.30%-18.03M
---7.75M
-38.59%-12.67M
---9.14M
Impairment and provision
-413.55%-796K
-168.26%-157K
88.13%-155K
141.82%230K
-164.81%-1.31M
---550K
-55.92%2.02M
--4.57M
-Other impairment is provision
-413.55%-796K
-168.26%-157K
88.13%-155K
141.82%230K
-164.81%-1.31M
---550K
-55.92%2.02M
--4.57M
Special items of operating profit
-5.54%45.58M
8.65%27.46M
35.93%48.25M
23.15%25.28M
91.53%35.5M
--20.52M
-1.17%18.53M
--18.75M
Operating profit
91.52%291.29M
319.65%155.47M
-45.30%152.09M
-73.35%37.05M
30.33%278.04M
139M
2.97%213.33M
207.18M
Financing income
605.79%21.84M
890.56%10.28M
141.15%3.09M
71.29%1.04M
13.14%1.28M
--606K
33.10%1.13M
--852K
Financing cost
-0.40%-24.81M
-2.07%-12.29M
-2.05%-24.71M
2.27%-12.05M
6.60%-24.22M
---12.33M
8.26%-25.93M
---28.26M
Share of profits of associates
---51K
----
----
----
----
----
----
----
Earning before tax
120.94%288.27M
489.31%153.46M
-48.85%130.48M
-79.54%26.04M
35.31%255.1M
127.28M
4.88%188.53M
179.76M
Tax
-191.48%-58.13M
-422.32%-32.34M
57.35%-19.94M
72.08%-6.19M
-28.66%-46.76M
---22.18M
-12.39%-36.35M
---32.34M
After-tax profit from continuing operations
108.21%230.14M
510.21%121.12M
-46.95%110.53M
-81.12%19.85M
36.90%208.34M
105.11M
3.23%152.19M
147.42M
Earning after tax
108.21%230.14M
510.21%121.12M
-46.95%110.53M
-81.12%19.85M
36.90%208.34M
105.11M
3.23%152.19M
147.42M
Minority profit
95.10%14.48M
96.57%9.29M
-50.07%7.42M
-42.08%4.73M
1,112.56%14.87M
--8.16M
-82.72%1.23M
--7.09M
Profit attributable to shareholders
109.15%215.66M
639.47%111.83M
-46.71%103.11M
-84.40%15.12M
28.16%193.48M
96.95M
7.58%150.96M
140.33M
Basic earnings per share
80.77%0.94
512.50%0.49
-46.39%0.52
-91.75%0.08
-35.76%0.97
0.97
7.09%1.51
1.41
Diluted earnings per share
80.77%0.94
512.50%0.49
-46.39%0.52
-91.75%0.08
-35.76%0.97
0.97
7.09%1.51
1.41
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Auditor
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
PricewaterhouseCoopers
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Turnover 31.16%2.15B41.20%1.04B-8.16%1.64B-12.25%734.32M18.46%1.78B--836.83M7.02%1.5B--1.4B
Operating income 31.16%2.15B41.20%1.04B-8.16%1.64B-12.25%734.32M18.46%1.78B836.83M7.02%1.5B1.4B
Cost of sales -27.29%-1.17B-32.95%-558.76M3.10%-917.57M6.16%-420.29M-17.89%-946.95M---447.88M-15.34%-803.27M---696.41M
Operating expenses -27.29%-1.17B-32.95%-558.76M3.10%-917.57M6.16%-420.29M-17.89%-946.95M-447.88M-15.34%-803.27M-696.41M
Gross profit 36.12%977.1M52.25%478.11M-13.91%717.84M-19.26%314.03M19.11%833.79M388.95M-1.17%700.02M708.34M
Selling expenses -31.66%-378.17M-38.82%-166.92M4.09%-287.23M7.75%-120.24M-10.70%-299.46M---130.34M2.68%-270.52M---277.97M
Administrative expenses -7.76%-318.35M0.85%-165.84M-8.44%-295.43M-26.87%-167.26M-21.60%-272.45M---131.84M5.61%-224.06M---237.38M
Research and development expenses -9.25%-34.07M-14.62%-17.18M-72.98%-31.19M-93.42%-14.99M-42.30%-18.03M---7.75M-38.59%-12.67M---9.14M
Impairment and provision -413.55%-796K-168.26%-157K88.13%-155K141.82%230K-164.81%-1.31M---550K-55.92%2.02M--4.57M
-Other impairment is provision -413.55%-796K-168.26%-157K88.13%-155K141.82%230K-164.81%-1.31M---550K-55.92%2.02M--4.57M
Special items of operating profit -5.54%45.58M8.65%27.46M35.93%48.25M23.15%25.28M91.53%35.5M--20.52M-1.17%18.53M--18.75M
Operating profit 91.52%291.29M319.65%155.47M-45.30%152.09M-73.35%37.05M30.33%278.04M139M2.97%213.33M207.18M
Financing income 605.79%21.84M890.56%10.28M141.15%3.09M71.29%1.04M13.14%1.28M--606K33.10%1.13M--852K
Financing cost -0.40%-24.81M-2.07%-12.29M-2.05%-24.71M2.27%-12.05M6.60%-24.22M---12.33M8.26%-25.93M---28.26M
Share of profits of associates ---51K----------------------------
Earning before tax 120.94%288.27M489.31%153.46M-48.85%130.48M-79.54%26.04M35.31%255.1M127.28M4.88%188.53M179.76M
Tax -191.48%-58.13M-422.32%-32.34M57.35%-19.94M72.08%-6.19M-28.66%-46.76M---22.18M-12.39%-36.35M---32.34M
After-tax profit from continuing operations 108.21%230.14M510.21%121.12M-46.95%110.53M-81.12%19.85M36.90%208.34M105.11M3.23%152.19M147.42M
Earning after tax 108.21%230.14M510.21%121.12M-46.95%110.53M-81.12%19.85M36.90%208.34M105.11M3.23%152.19M147.42M
Minority profit 95.10%14.48M96.57%9.29M-50.07%7.42M-42.08%4.73M1,112.56%14.87M--8.16M-82.72%1.23M--7.09M
Profit attributable to shareholders 109.15%215.66M639.47%111.83M-46.71%103.11M-84.40%15.12M28.16%193.48M96.95M7.58%150.96M140.33M
Basic earnings per share 80.77%0.94512.50%0.49-46.39%0.52-91.75%0.08-35.76%0.970.977.09%1.511.41
Diluted earnings per share 80.77%0.94512.50%0.49-46.39%0.52-91.75%0.08-35.76%0.970.977.09%1.511.41
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified Opinion
Auditor PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopersPricewaterhouseCoopers

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg